Jim Simons Inovio Pharmaceuticals, Inc. Transaction History

Renaissance Technologies LLC

$63.1 Billion
Q3 2024

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 13, 2024	BUY	$0.35 - $0.53 $842,757 - $1.28 Million	2,407,879 Added 49.25%	7,297,379 $3.72 Million
Q3 2023 Nov 14, 2023	SELL	$0.38 - $0.58 $207,776 - $317,132	-546,781 Reduced 10.06%	4,889,500 $1.9 Million
Q2 2023 Aug 11, 2023	BUY	$0.39 - $0.94 $1.09 Million - $2.63 Million	2,795,981 Added 105.9%	5,436,281 $2.43 Million
Q1 2023 May 12, 2023	BUY	$0.79 - $1.91 $53,562 - $129,498	67,800 Added 2.64%	2,640,300 $2.17 Million
Q4 2022 Feb 13, 2023	BUY	$1.41 - $2.5 $350,808 - $622,000	248,800 Added 10.71%	2,572,500 $4.01 Million
Q3 2022 Nov 14, 2022	BUY	$1.66 - $2.79 $1.24 Million - $2.08 Million	746,200 Added 47.3%	2,323,700 $4.01 Million
Q2 2022 Aug 12, 2022	BUY	$1.44 - $3.98 $1.7 Million - $4.71 Million	1,183,619 Added 300.5%	1,577,500 $2.73 Million
Q1 2022 May 13, 2022	BUY	$2.97 - $5.2 $1.17 Million - $2.05 Million	393,881 New	393,881 $1.41 Million
Q2 2020 Aug 13, 2020	SELL	$7.14 - $31.69 $4.31 Million - $19.1 Million	-603,123 Closed	0 $0
Q1 2020 May 14, 2020	BUY	$2.98 - $14.09 $725,996 - $3.43 Million	243,623 Added 67.77%	603,123 $4.49 Million
Q4 2019 Feb 13, 2020	BUY	$1.97 - $3.72 $442,462 - $835,512	224,600 Added 166.49%	359,500 $1.19 Million
Q3 2019 Nov 13, 2019	SELL	$2.05 - $3.02 $163,551 - $240,938	-79,781 Reduced 37.16%	134,900 $277,000
Q2 2019 Aug 12, 2019	SELL	$2.29 - $4.1 $800,584 - $1.43 Million	-349,600 Reduced 61.95%	214,681 $631,000
Q1 2019 May 14, 2019	BUY	$3.34 - $5.1 $764,860 - $1.17 Million	229,000 Added 68.3%	564,281 $2.11 Million
Q4 2018 Feb 13, 2019	BUY	$3.89 - $6.11 $1.3 Million - $2.05 Million	335,281 New	335,281 $1.34 Million

Others Institutions Holding INO

# of Institutions

Shares Held

281K

Call Options Held

Put Options Held

View Full List

About INOVIO PHARMACEUTICALS, INC.

Ticker INO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 249,400,000
Market Cap $521M
Description
Inovio Pharmaceuticals, Inc., a biotechnology company, focuses on the discovery, development, and commercialization of DNA medicines to treat and protect people from diseases associated with human papillomavirus (HPV), cancer, and infectious diseases. Its DNA medicines platform uses precisely designed SynCon that identify and optimize the DNA se...

More about INO

Track Jim Simons's Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Renaissance Technologies LLC, based on Form 13F filings with the SEC.

News

Stay updated on Renaissance Technologies LLC and Jim Simons with notifications on news.

Account